Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | WVT078 |
Trade Name | |
Synonyms | WVT-078|WVT 078 |
Drug Descriptions |
WVT078 is a bispecific antibody that targets the B-cell maturation antigen (BCMA; TNFRSF17) expressed on tumor cells and the T-cell antigen CD3, potentially resulting in activation of cytotoxic T-lymphocytes (CTLs) and killing of BCMA-expressing tumor cells (NCI Thesaurus). |
DrugClasses | CD3 Antibody 99 TNFRSF17 Antibody 20 |
CAS Registry Number | NA |
NCIT ID | C181676 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
WVT078 | WVT078 | 0 | 1 |